American giant Pfizer, the world's biggest drug maker, with 68 billion dollars (50 billion euros) in turnover in 2010, has become the owner of a food supplements plant in Cluj, with over 5 million euros in annual sales.
The Ferrosan plant in Cluj, which produces Multi Tabs (vitamins, minerals and Omega 3), Bifiform (probiotic products), Zinaxin (joint relief), was taken over as part of the acquisition of Danish company Ferrosan Consumer Healthcare in an international transaction. Ferrosan posted 150 million euros in turnover in 2009.
The deal, which is set to be finalised in the second quarter of the year, marks Pfizer's entry onto the production segment of the Romanian pharmaceutical market, with the company being present only as an importer so far. The value of the deal was not made public. In 2010, Pfizer ranked third among the top players on the Romanian drug market, with 628.1 million lei (150 million euros) in sales and a 6.5% market share, according to market research and analysis company Cegedim.
American giant Pfizer, the world's biggest drug maker, with 68 billion dollars (50 billion euros) in turnover in 2010, has become the owner of a food supplements plant in Cluj, with over 5 million euros in annual sales.
The Ferrosan plant in Cluj, which produces Multi Tabs (vitamins, minerals and Omega 3), Bifiform (probiotic products), Zinaxin (joint relief), was taken over as part of the acquisition of Danish company Ferrosan Consumer Healthcare in an international transaction. Ferrosan posted 150 million euros in turnover in 2009.
The deal, which is set to be finalised in the second quarter of the year, marks Pfizer's entry onto the production segment of the Romanian pharmaceutical market, with the company being present only as an importer so far. The value of the deal was not made public. In 2010, Pfizer ranked third among the to
